Alzheimer in Medical Technology

Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND

LAUSANNE, Switzerland, October 21 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, announced today that the first healthy elderly subjects have been randomised in a clinical bi...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

...ria at Messe Wien Exhibition and Congress Center from July 11-16. The Alzheimer's Association is the leading voluntary health organization in alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and suppo...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

...Center from July 11-16. About the Alzheimer's Association The Alzheimer's Association is the leading voluntary health organization in alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and suppo...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

...Center from July 11-16. About the Alzheimer's Association The Alzheimer's Association is the leading voluntary health organization in alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and suppo...

Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion

...ll be presented by Anders Wimo, MD, PhD, of the KI alzheimer Disease Research Center, Karolinska Institutet , ... "Later this year, ADI will launch the first World alzheimer Report alerting governments, policymakers and dono...n Huddinge will talk about "Emerging treatment for alzheimer disease." Winblad, an experienced leader of c...

AFFiRiS Begins Development of a Parkinson's Vaccine

...found on harmful fragments of beta-amyloid, which is said to be responsible for Alzheimer's. Both Alzheimer's vaccines are currently being trialled on alzheimer patients. In October, a licence option agreement worth up to EUR 430 million was concluded with GlaxoSmithKline Biologicals for their further clinical...

Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease

...chaturian, ZS, Lebowitz, BD, McRae, TD, Morris, JC, Oakley, F, Schneider, LS, Streim, JE, Sunderland, T, Teri, LA, Tune LE. Diagnosis and Treatment of alzheimer Disease and Related Disorders: Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American...

Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD

...08 The 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008) is the largest gathering of international leaders in alzheimer research and care ever convened. At ICAD 2008, more than 5,000 researchers from 60 countries will share groundbreaking information and resources on th...

Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation

...he pre-clinical models. At ICAD 2008, Philip Scheltens, MD, Ph.D., of the alzheimer Center of the VU University Medical Centre, Amsterdam, the Netherlands repo...'s Disease (ICAD 2008) is the largest gathering of international leaders in alzheimer research and care ever convened. At ICAD 2008, more than 5,000 researchers ...

Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets

...AD The 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008) is the largest gathering of international leaders in alzheimer research and care ever convened. At ICAD 2008, more than 5,000 researchers from 60 countries will share groundbreaking information and resources on th...

Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials

...educe the ability to show the effectiveness of new alzheimer therapies, according to new research reported toda...e on Alzheimer's Disease (ICAD 2008) in Chicago. alzheimer clinical trials seek to show that those who receiv... lesser degree. A complication that is emerging in alzheimer clinical trials is the perception that participant...

AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine

... VIENNA, Austria, July 16 /PRNewswire/ -- In the clinical phase I trial AFF001, AFFiRiS GmbH has now recruited the 24 alzheimer patients planned for this trial. The trial aims to investigate the tolerability and safety of an innovative Alzheimer's vaccine (AFFITOPE AD01). In th...

Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans

...rector, Clinical Development. Dr. Gregory brings more than 15 years of biotechnology/pharmaceutical and academic experience, with special attention to alzheimer disease, Parkinson disease and multiple sclerosis. Dr. Nakas applies more than 22 years of clinical, academic and industry research experience in mult...

Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease

...owitz, BD, McRae, TD, Morris, JC, Oakley, F, Schneider, LS, Streim, JE, Sunderland, T, Teri, LA, Tune LE. Diagnosis and Treatment of alzheimer Disease and Related Disorders: Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and ...

ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans

...h a novel mechanism of action, which has shown preclinical benefits on memory and neuronal loss and is currently tested in a Phase 2 clinical trial on alzheimer disease (AD) patients. Scopolamine interferes with the transmission of nerve impulses by acetylcholine, a substance to which it is structurally simi...

MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies

...nformation visit http://www.medicalert.org The Alzheimer's Association The Alzheimer's Association is the leading voluntary health organization in alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and suppo...

Sarasota's Roskamp Institute Announces Positive Safety Data in Human Clinical Study for Alzheimer's Disease

...skamp Institute. "A staggering number of drugs fail once they go through their clinical studies due to safety issues. After treating more than a dozen alzheimer patients with Nilvadipine, we can continue our studies because we have seen no serious side effects related to the drug." This pilot study was th...

Treating Heart Disease Risk Factors May Slow Alzheimer's Disease Progression

...f weight. In a subset of 363 Catholic sisters who died during the study, the associations of weight at baseline and the final weight before death with alzheimer brain changes (as measured using Braak stages) were assessed. In the same group, age- and education-adjusted associations of baseline weight and final...

Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimer's Disease at International Conference on Prevention of Dementia

...nch research, drug discovery, medicine, care and public policy, is hosted by the Alzheimer's Association, the leading voluntary health organization in alzheimer care, support and research. About AC-1202 Brain imaging techniques performed on AD patients reveal a dramatically decreased uptake of glucose, the...